Cooley adds Mintz Levin life sciences patent team

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Cooley adds Mintz Levin life sciences patent team

Cooley has added a life sciences patent team led by Ivor Elrifi, the former co-chair of Mintz Levin’s IP practice, and fellow former Mintz Levin partner Heidi Erlacher

ivor20elrifi20heidi20erlacher.jpg

Elrifi, Erlacher and their team will be based in Cooley’s Boston and New York offices. Four former Mintz Levin partners are joining Elrifi and Erlacher at Cooley.

Elrifi has advised companies around the world in various industries, including pharmaceutical, biotechnology and life sciences, on developing patent strategies and in the prosecution, licensing and enforcement of patents.

Erlacher advises clients on patent strategy, counseling and prosecution for life sciences companies, including pharmaceutical companies, in areas such as chemistry, biochemistry and biotechnology.

 

more from across site and SHARED ros bottom lb

More from across our site

The IP boutique is betting that growing investment in quantum and semiconductors will fuel demand as technology shifts toward physical systems
Lawyers say the overhaul better reflects commercial reality, with changes spanning novelty searches, digital designs and access to a small claims track, but stopping short of criminalising unregistered design infringement
Carpmaels & Ransford hires its fourth partner of the year and wins access to UPC files, as fresh orders address costs, confidentiality and the use of divisional patents
Peter Ling of Lenz & Staehelin in Zurich discusses trends in patent litigation, the regulation of AI and the benefits of teaching IP
Brandsmiths and Powell Gilbert will contest claims over several UK trademarks in a High Court case examining the ownership and revival of a heritage brand
Hogan Lovells Cadwalader is taking a fresh strategic approach to pricing in its AI strategy. It could amplify calls for law firms to ditch the billable hour
Charles Harding plans to build a new team around life sciences oppositions and contentious work, drawing on his three decades developing a practice from scratch at D Young & Co
The firm reveals how its litigation strategies informed the arguments that took Masimo’s judgment past $818 million
The firm was rebuilding its IP practice through a string of patent hires and a Texas expansion, but its dissolution has put the newly built talent back into the market
AI can exploit longstanding gaps in copyright protection at remarkable speed, but EU law still provides tools to fight back, says Simon Hembt at Bird & Bird
Gift this article